Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cells

Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cells

Thumbnail Image
Download
Name

1-s2.0-S2211124722005162-main.pdf

Description
Published version
Size

5.26 MB

Format

Adobe PDF

Checksum (MD5)

fd1a25d9707e3a4d87e8163698b7a342

sword-2023-02-02T18:49:58.original.xml (130 B)
Original SWORD entry document
Author(s)
Morris, Vivian
•
Wang, Dahai
•
Li, Zhiheng
•
Marion, William
•
Hughes, Travis
•
Sousa, Patricia
•
Harada, Taku
•
Sui, Shannan Ho
•
Naumenko, Sergey
•
Kalfon, Jérémie
more
Date Issued
2022
Journal
Cell Reports
Publisher
Elsevier BV
Citation
Morris, Vivian, Wang, Dahai, Li, Zhiheng, Marion, William, Hughes, Travis et al. 2022. "Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cells." Cell Reports, 39 (4).
Version
Final published version
Abstract
High-risk forms of B-acute lymphoblastic leukemia (B-ALL) remain a therapeutic challenge. Leukemia-initiating cells (LICs) self-renew and spark relapse and therefore have been the subject of intensive investigation; however, the properties of LICs in high-risk B-ALL are not well understood. Here, we use single-cell transcriptomics and quantitative xenotransplantation to understand LICs in MLL-rearranged (MLL-r) B-ALL. Compared with reported LIC frequencies in acute myeloid leukemia (AML), engraftable LICs in MLL-r B-ALL are abundant. Although we find that multipotent, self-renewing LICs are enriched among phenotypically undifferentiated B-ALL cells, LICs with the capacity to replenish the leukemic cellular diversity can emerge from more mature fractions. While inhibiting oxidative phosphorylation blunts blast proliferation, this intervention promotes LIC emergence. Conversely, inhibiting hypoxia and glycolysis impairs MLL-r B-ALL LICs, providing a therapeutic benefit in xenotransplantation systems. These findings provide insight into the aggressive nature of MLL-r B-ALL and provide a rationale for therapeutic targeting of hypoxia and glycolysis.
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Terms of Use
Creative Commons Attribution-NonCommercial-NoDerivs License
http://creativecommons.org/licenses/by-nc-nd/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/147849
DOI of Published Version
https://doi.org/10.1016/J.CELREP.2022.110752
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.